Literature DB >> 7018725

2'-deoxycoformycin. A new anticancer agent.

D S Poster, J S Penta, S Bruno, J S Macdonald.   

Abstract

2'-deoxycoformycin (2'-dCF) is a powerful inhibitor of adenosine deaminase (ADA), an enzyme found in high concentrations in lymphoid tissue. Although inactive in preclinical tumor models, 2'-dCF has shown clinical antitumor activity as a single agent in lymphoid malignancies. This drug has the added potential of being useful as a potentiator of other antitumor agents which are deactivated by ADA. It is also possible that the drug has potential as an immunosuppressive agent. Phase I studies are ongoing and phase II trials are planned to define the antitumor spectrum of this agent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018725

Source DB:  PubMed          Journal:  Cancer Clin Trials        ISSN: 0190-1206


  3 in total

1.  Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Authors:  R O Dillman; A L Yu; C N Qiao
Journal:  West J Med       Date:  1988-03

2.  Adenine aminohydrolase from Leishmania donovani: unique enzyme in parasite purine metabolism.

Authors:  Jan M Boitz; Rona Strasser; Charles U Hartman; Armando Jardim; Buddy Ullman
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

Review 3.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.